Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SGLT2 inhibition in a kidney with reduced nephron number: modeling and analysis of solute transport and metabolism
Anita T. Layton, Volker Vallon
AJP Renal Physiology (2018) Vol. 314, Iss. 5, pp. F969-F984
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function
Volker Vallon, Subodh Verma
Annual Review of Physiology (2020) Vol. 83, Iss. 1, pp. 503-528
Open Access | Times Cited: 325
The tubular hypothesis of nephron filtration and diabetic kidney disease
Volker Vallon, Scott C. Thomson
Nature Reviews Nephrology (2020) Vol. 16, Iss. 6, pp. 317-336
Open Access | Times Cited: 324
Development of SGLT1 and SGLT2 inhibitors
Timo Rieg, Volker Vallon
Diabetologia (2018) Vol. 61, Iss. 10, pp. 2079-2086
Open Access | Times Cited: 290
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
David Z.I. Cherney, Claire C. J. Dekkers, Sean J. Barbour, et al.
The Lancet Diabetes & Endocrinology (2020) Vol. 8, Iss. 7, pp. 582-593
Open Access | Times Cited: 213
A role for tubular Na+/H+exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin
Akira Ōnishi, Yiling Fu, Rohit Patel, et al.
AJP Renal Physiology (2020) Vol. 319, Iss. 4, pp. F712-F728
Open Access | Times Cited: 166
Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics
Milton Packer
American Journal of Kidney Diseases (2020) Vol. 77, Iss. 2, pp. 280-286
Open Access | Times Cited: 162
The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?
Anne C. Hesp, Jennifer A. Schaub, Pottumarthi V. Prasad, et al.
Kidney International (2020) Vol. 98, Iss. 3, pp. 579-589
Open Access | Times Cited: 145
A kidney perspective on the mechanism of action of sodium glucose co-transporter 2 inhibitors
Taha Sen, Hiddo J.L. Heerspink
Cell Metabolism (2021) Vol. 33, Iss. 4, pp. 732-739
Open Access | Times Cited: 111
Metabolic Communication by SGLT2 Inhibition
A. Billing, Young Chul Kim, Søren Gullaksen, et al.
Circulation (2023) Vol. 149, Iss. 11, pp. 860-884
Open Access | Times Cited: 58
Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes
Milton Packer, Christopher S. Wilcox, Jeffrey M. Testani
Circulation (2023) Vol. 148, Iss. 4, pp. 354-372
Open Access | Times Cited: 49
SGLT2 inhibition and kidney protection
Josselin Nespoux, Volker Vallon
Clinical Science (2018) Vol. 132, Iss. 12, pp. 1329-1339
Open Access | Times Cited: 159
Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors
Christopher S. Wilcox
Hypertension (2020) Vol. 75, Iss. 4, pp. 894-901
Open Access | Times Cited: 122
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
Katherine R. Tuttle, Frank C. Brosius, Matthew A. Cavender, et al.
American Journal of Kidney Diseases (2020) Vol. 77, Iss. 1, pp. 94-109
Open Access | Times Cited: 111
Renal effects of SGLT2 inhibitors
Josselin Nespoux, Volker Vallon
Current Opinion in Nephrology & Hypertension (2019) Vol. 29, Iss. 2, pp. 190-198
Open Access | Times Cited: 103
Glucose transporters in the kidney in health and disease
Volker Vallon
Pflügers Archiv - European Journal of Physiology (2020) Vol. 472, Iss. 9, pp. 1345-1370
Open Access | Times Cited: 102
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
Katherine R. Tuttle, Frank C. Brosius, Matthew A. Cavender, et al.
Diabetes (2020) Vol. 70, Iss. 1, pp. 1-16
Open Access | Times Cited: 80
Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments
Mehrshad Sadria, Anita T. Layton
Viruses (2021) Vol. 13, Iss. 6, pp. 1141-1141
Open Access | Times Cited: 68
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
João Pedro Ferreira, Faı̈ez Zannad, Javed Butler, et al.
European Heart Journal (2022) Vol. 43, Iss. 31, pp. 2984-2993
Open Access | Times Cited: 59
The mixed blessing of AMPK signaling in Cancer treatments
Mehrshad Sadria, Deokhwa Seo, Anita T. Layton
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 55
Functional and Clinical Importance of SGLT2-inhibitors in Frailty: From the Kidney to the Heart
Gaetano Santulli, Fahimeh Varzideh, Imma Forzano, et al.
Hypertension (2023) Vol. 80, Iss. 9, pp. 1800-1809
Open Access | Times Cited: 39
Sex differences in renal transporters: assessment and functional consequences
Alicia A. McDonough, Autumn N. Harris, Lingyun Xiong, et al.
Nature Reviews Nephrology (2023) Vol. 20, Iss. 1, pp. 21-36
Open Access | Times Cited: 27
State-of-the-art-review Mechanisms of action of SGLT2 inhibitors and clinical implications
Volker Vallon
American Journal of Hypertension (2024) Vol. 37, Iss. 11, pp. 841-852
Closed Access | Times Cited: 13
How can inhibition of glucose and sodium transport in the early proximal tubule protect the cardiorenal system?
Volker Vallon
Nephrology Dialysis Transplantation (2024) Vol. 39, Iss. 10, pp. 1565-1573
Closed Access | Times Cited: 12
Effects of sotagliflozin on kidney and cardiac outcome in a hypertensive model of subtotal nephrectomy in male mice
Helen Goodluck, Alice Zemljic‐Harpf, Ony Araújo Galdino, et al.
Physiological Reports (2025) Vol. 13, Iss. 7
Open Access | Times Cited: 1
Functional implications of sexual dimorphism of transporter patterns along the rat proximal tubule: modeling and analysis
Qianyi Li, Alicia A. McDonough, Harold E. Layton, et al.
AJP Renal Physiology (2018) Vol. 315, Iss. 3, pp. F692-F700
Open Access | Times Cited: 78
Page 1 - Next Page

Scroll to top